APPLIED BIOSYSTEMS REPORTS 30% INCREASE IN 2ND QTR
EARNINGS.(Brief Article)
Applied Biosystems Group (NYSE:ABI), Foster City, Calif., a
business of Applera Corporation, has reported that earnings per share in
the second quarter of fiscal 2001, ended December 31, 2000, . . .
PHARSIGHT REVENUES INCREASE 52% FOR 3RD QUARTER.(Pharsight Corp.,
fiscal year 2001)(Brief Article)(Company Profile)(Statistical
Pharsight Corporation (Nasdaq:PHST), Mountain View, Calif., a
leading provider of technologies and services that improve the drug
development process, has announced results for the third quarter . . .
CELERA GENOMICS REPORTS $20.3 MILLION 2ND QTR REVENUES.(Brief
Article)
Celera Genomics Group (NYSE:CRA), Rockville, Md., a business of
Applera Corporation, has reported results for its second fiscal quarter
ended December 31, 2000. The Group's revenues for the . . .
SIMULATIONS PLUS REPORTS 30% INCREASE IN FIRST QUARTER
2001.(sales information)(Brief Article)(Statistical Data
Included)
Simulations Plus Inc. (OTCBB:SIMU) (www.simulations-plus.com), a
provider of ADME neural net and absorption simulation software for
pharmaceutical discovery and development, has reported its . . .
VASOMEDICAL REPORTS 118% NET INCOME INCREASE IN SECOND
QUARTER.(sales information)(Brief Article)(Statistical Data
Included)
Vasomedical, Inc. (Nasdaq: VASO) has reported that its net income
for the fiscal 2001 second quarter rose to $1.7 million, or $0.03 per
share, versus net income of $54,000, or nil per share, for . . .
FORBES MEDI-TECH REPORTS 1ST QTR NET LOSS OF $0.17 PER
SHARE.(profit information)(Brief Article)(Statistical Data
Included)
Forbes Medi-Tech (Nasdaq:FMTI)(TSE:FMI.) has reported its
financial results for the first quarter of fiscal 2001 ending October
31, 2000.
The company incurred a net loss for the fiscal first . . .
ORGANOGENESIS 4TH QUARTER APLIGRAF SALES SURPASS 4000
UNITS.(sales information)(Brief Article)(Statistical Data
Included)
Organogenesis Inc. (AMEX:ORG) has reported that US commercial
sales of lead product Apligraf reached 4084 units for the fourth quarter
of 2000, up from 3232 units for the previous quarter. This . . .
GENESIS HEALTH VENTURES REPORTS $2.4 BILLION IN REVENUE.(sales
information)(Brief Article)(Statistical Data Included)
Genesis Health Ventures, Inc. (OTCBB: ghviq) has reported results
for its fiscal year ended September 30, 2000.
Revenues for the fiscal year ended September 30, 2000 were $2.4
billion and . . .
ART REPORTS NET LOSS OF $2.0 MILLION IN SECOND QUARTER.(Company
Profile)(Statistical Data Included)
ART Advanced Research Technologies Inc., (ART) (TSE: ARA) has
reported that during the second quarter ended October 31, 2000, the
company achieved a very significant milestone by completing, . . .
SYNSORB BIOTECH REPORTS $0.064 PER SHARE LOSS IN THIRD
QUARTER.(Company Profile)(Statistical Data Included)
SYNSORB Biotech Inc. ("SYNSORB") (TSE:SYB.)(Nasdaq:SYBB)
has reported its results for the third quarter and nine month period
ended September 30, 2000.
As well as demonstrating improved . . .
MINNTECH REPORTS NET EARNINGS OF $1.3 MILLION FOR 2ND. QTR.(Brief
Article)
Minntech Corporation (Nasdaq: MNTX), Minneapolis, has reported
financial results for the second quarter ended September 30, 2000.
Revenues in the second quarter of fiscal 2001 were $18.0 . . .
MEDSTONE REPORTS 15% DECREASE IN THIRD QTR. REVENUE.(Brief
Article)
Medstone International, Inc. (Nasdaq:MEDS), Aliso Viejo, Calif.,
has reported revenues of $5,442,870 for the third quarter ending
September 30, 2000, a 15% revenue decrease compared to $6,439,634 . . .
INHALE REPORTS INCREASE IN 3RD. QTR. CONTRACT REVENUE.(Brief
Article)
Inhale Therapeutic Systems, Inc. (NASDAQ:INHL), San Carlos,
Calif., has announced its financial results for the third quarter ended
September 30, 2000. The company reported contract research . . .
CERUS REPORTS NET LOSS OF $9.2 MILLION FOR 3RD. QTR.(Brief
Article)
Cerus Corporation (Nasdaq:CERS), Concord, Calif., a pioneer in
systems to enhance the safety of the world's blood supply, has
announced results for the third quarter ended Sept. 30, 2000.
The . . .
RADIANCE REPORTS 27% INCREASE IN THIRD QTR. REVENUE.(Brief
Article)
Radiance Medical Systems Inc., (Nasdaq:RADX), Irvine, Calif, has
announced that revenue for the third quarter ended Sept. 30, 2000,
increased by 27 percent to $1,876,000, compared with $1,474,000 . . .
GENENTECH REPORTS 25% INCREASE IN SALES FOR 3RD. QTR.(Brief
Article)
Genentech, Inc. (NYSE:DNA), South San Francisco, has announced a
25 percent increase in product sales driven by Genentech's oncology
drugs and a 19 percent increase in earnings per share(1) for . . .
BIOGEN REPORTS 10% INCREASE IN NET INCOME FOR 3RD QTR.(Brief
Article)
Biogen, Inc. (Nasdaq: BGEN), Cambridge, Mass., has reported
financial results for the third quarter of 2000. For the three months
ended September 30, 2000, the company reported net income . . .
LCA-VISION POSTS 86% VOLUME INCREASE IN 3RD. QTR.
PROCEDURES.(Brief Article)
LCA-Vision Inc. (NASDAQ NM: LCAV), Cincinnati, a leading U.S.
provider of laser vision correction services, has reported an 86%
increase in consolidated procedure volume for the third quarter of . . .
FONAR REPORTS REVENUE INCREASE AND NET LOSS DECREASE.(Brief
Article)
FONAR Corporation (NASDAQ-FONR), Melville, N.Y., The Patient-
Friendly(TM) MRI Company, has reported revenues of $39.1 million for the
fiscal year ended June 30, 2000, as compared to the $36.9 . . .
ISONICS REPORTS REVENUE INCREASE OF 25% OVER PRIOR QTR.(Brief
Article)
Isonics Corporation (NASD: ISON), Golden, Colo., has reported
revenues of $2.0 million for the period ending July 31, 2000, an
increase of 25% over revenues for the prior quarter. Additionally . . .
|
|